DXB.AX · DIMERIX LIMITED
Australia · RS rating 15 · As of 2026-10-14
| Price | 0.21 AUD |
|---|---|
| 1-day change | -4.5% |
| RS rating (overall / 1M / 3M / 12M) | 15 / 30 / 33 / 16 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 20 / 12 / 17 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +66.4% |
| Market cap (USD) | $91.9M |